Price$56.23-1.13 (-1.96%)
01:30 PM07:45 PM
News · 26 weeks61+100%
2025-12-282026-06-21
Mix2690d
- Insider9(35%)
- Other8(31%)
- SEC Filings7(27%)
- Earnings2(8%)
Latest news
25 items- INSIDERDirector Swartz David L sold $145,449 worth of shares (2,699 units at $53.89), decreasing direct ownership by 2% to 177,013 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- INSIDERPres & CEO, Digital Health Wesdorp Cornelis sold $276,022 worth of shares (4,750 units at $58.11), decreasing direct ownership by 6% to 69,075 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- INSIDERPresident, CEO Berger Howard G gifted 90 shares (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- INSIDERPres & CEO-Eastern Operations Forthuber Stephen M sold $2,562,911 worth of shares (44,067 units at $58.16), decreasing direct ownership by 8% to 507,199 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- SECRadNet Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - RadNet, Inc. (0000790526) (Filer)
- PRRadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it has entered into Incremental Amendment No. 3 (the "Third Amendment") to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the "Existing Credit Agreement" and, as amended by the Third Amendment, the "Credit Agreement"). Pursuant to the Third Amendment, certain term lenders under the Credit Agreement funded RadNet an incremental t
- PRDeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology ReportingSOMERVILLE, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ:RDNT), today announced the launch of Reporting Pro, a next-generation AI-powered solution designed to transform the way radiologists generate clinical reports and findings for their referring physicians. Reporting Pro was introduced at RSNA 2025 and is now available for commercial deployment. Reporting Pro includes capabilities that bring speech recognition, AI-generated clinical findings, measurements, AI-generated impressions, quality assurance and structured reporting into one seamless workflow. "Radiology is ent
- SECRadNet Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - RadNet, Inc. (0000790526) (Filer)
- INSIDERDirector Swartz David L was granted 2,946 shares, increasing direct ownership by 2% to 179,712 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- INSIDERDirector Spurlock Gregory E. was granted 2,946 shares, increasing direct ownership by 56% to 8,236 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- INSIDERDirector Jacobs Laura Pastre was granted 2,946 shares, increasing direct ownership by 11% to 29,953 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- INSIDERDirector Levitt Lawrence L was granted 2,946 shares, increasing direct ownership by 2% to 167,902 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- SECRadNet Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - RadNet, Inc. (0000790526) (Filer)
- PRRadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth OpportunitiesLOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT) ("RadNet"), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it seeks to secure an incremental term loan in the aggregate principal amount of $200 million (the "Proposed 2026 Incremental Term Loan") pursuant to a proposed amendment (the "Proposed Amendment") to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the "Existing Credit Agreement" and, the transaction, the "Loan Transaction"). If
- PRRadNet to Host Men's Health Webinar on June 13, 2026LOS ANGELES, May 28, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of over 440 outpatient imaging centers and a premier developer of radiology digital health solutions, today announced it will host a free webinar for patients and the general public on Saturday, June 13, 2026, in recognition of National Men's Health Month. The event will feature presentations by radiologists on three of the most significant health conditions affecting American men today: coronary artery disease, prostate cancer and lung cancer. The clinical case for increased attention to
- PRCardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsIssued on behalf of Ventripoint Diagnostics Ltd.A Toronto-based small-cap is converting clinical validation into real-world hospital deployments at the moment AI cardiac imaging procurement is reorganizing globallyNEW YORK, May 19, 2026 /CNW/ -- USA News Group News Commentary — Cardiology has become one of the proving grounds for medical artificial intelligence, and the procurement environment around it has shifted hard in the last twelve months. Hospital networks are no longer content to evaluate clinical accuracy in isolation; they want department-level economic proof before they sign deployment contracts. That shift is reshaping which AI imaging companies can convert pilot data into recur
- SECSEC Form SCHEDULE 13G filed by RadNet Inc.SCHEDULE 13G - RadNet, Inc. (0000790526) (Subject)
- SECSEC Form 10-Q filed by RadNet Inc.10-Q - RadNet, Inc. (0000790526) (Filer)
- SECRadNet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - RadNet, Inc. (0000790526) (Filer)
- PRRadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash FlowTotal Company Revenue increased 22.1% to $575.6 million in the first quarter of 2026 from $471.4 million in the first quarter of 2025Revenue from the Digital Health reportable segment increased 51.5% to $29.1 million in the first quarter of 2026 from $19.2 million in the first quarter of 2025; Annual Recurring Revenue(4) (ARR) increased from $49.8 million at March 31, 2025 to $96.9 million at March 31, 2026Total Company Adjusted EBITDA(1) was $63.3 million in the first quarter of 2026 as compared with $46.4 million in the first quarter of 2025, an increase of 36.3%; Digital Health reportable segment Adjusted EBITDA(1) decreased to $1.3 million in the first quarter of 2026 from $3.7 million i
- INSIDERPresident, CEO Berger Howard G exercised 25,992 shares at a strike of $18.64, increasing direct ownership by 6% to 498,405 units (SEC Form 4)4 - RadNet, Inc. (0000790526) (Issuer)
- PRRadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference CallLOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today that it will host a conference call to discuss its first quarter 2026 financial results on Monday, May 11, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet's conference call by dialing 844-744-1280. International callers can dial 412-564-6465. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1761306&tp_key=ea5d61284c. An archived replay of the call will also be available
- SECSEC Form DEFA14A filed by RadNet Inc.DEFA14A - RadNet, Inc. (0000790526) (Filer)
- SECSEC Form DEF 14A filed by RadNet Inc.DEF 14A - RadNet, Inc. (0000790526) (Filer)
- PRGE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutionsThe expanded collaboration builds on the companies' existing joint initiative by bringing to market enhanced capabilities of DeepHealth's new AI-powered Breast Suite, including ProFound Pro and Safeguard Review GE HealthCare to feature latest technologies to help ensure optimized breast care outcomes across mammography and ultrasound at SBI's 2026 Breast Cancer Imaging Symposium GE HealthCare (NASDAQ:GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ:RDNT), to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The an
RDNT FAQ
6 questionsWhat does RadNet Inc. do?
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems. As of March 8, 2021, it owned and/or operated 331 centers in Arizona, California...Where does RDNT stock trade?
RadNet Inc. (RDNT) is listed on NASDAQ.What sector and industry is RDNT in?
RadNet Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about RDNT?
RadNet Inc. has had 8 recent analyst actions on file. The most recent action was from KeyBanc Capital Markets: Overweight on 2026-01-09. Recent price targets range from $3000.00 to $4800.00.What companies are similar to RDNT?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare RDNT side-by-side with any of them on Quantisnow.How can I track RDNT on Quantisnow?
Quantisnow aggregates RadNet Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RDNT to receive live email and push alerts on every new disclosure.